Press releases
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
2 Apr 24
Press Releases
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial
19 Mar 24
Press Releases
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
1 Mar 24
Press Releases
Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th
28 Feb 24
Press Releases
Results from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months
14 Feb 24
Press Releases